Laurence is an avid writer, gamer, and traveller with several years of journalistic writing experience under his belt. Having helped create a student-focused magazine at university, he is keen to ...
Arc Raiders sends you to Blue Gate for the Keeping an Eye Out quest, once again tasking you with finding one of Bilguun's hideouts. This time, you're seeking his shelter at the collapsed highway, ...
Eyes are beautifully diverse, coming in various sizes, colors, and shapes—and each one deserves to be spotlighted at its best. Naturally, with each eye shape comes different makeup tricks and tips to ...
If you’ve noticed it’s more difficult to focus on objects up close as you age, you’re not alone. Approximately 128 million Americans suffer from a common form of vision loss—and the number is only ...
"As the first FDA-approved dual-agent eye drop for presbyopia, Yuvezzi leverages the mechanisms of carbachol and brimonidine tartrate to deliver sharp near vision with favorable tolerability." ...
The US Food and Drug Administration has approved a landmark eye drop that uses a combined dose of medication to restore age-related near-sightedness, without the need for surgery, for a longer ...
A chemical used in some over-the-counter eye drops may affect liver cells and be transformed to a PFAS-like substance. This is according to a new study from Örebro University published in Environment ...
To help promote the second season of Apple TV’s Drops of God, the company has released an Apple Maps guide with some of actor Tomohisa Yamashita’s favorite wineries in Europe and the US. Here are the ...
Eye redness was not a commonly reported side effect in clinical trials of YUVEZZI. In BRIO I and BRIO II the reports of adverse events of ocular hyperemia (eye redness) were low. 1,2 In BRIO II, the ...
The FDA has approved YUVEZZI, the first dual-agent eye drop, to treat presbyopia, a leading cause of vision loss in adults. The medication uses a fixed-dose combination of carbachol (2.75%) and ...
Combining two eye drops that have been on the market for at least 30 years each has earned Tenpoint Therapeutics an FDA approval (PDF) for Yuvezzi, a treatment for presbyopia, a common, age-related ...
Please provide your email address to receive an email when new articles are posted on . The dual-agent ophthalmic solution significantly improves presbyopia for up to 10 hours. It is expected to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results